MetaCap

C4 Therapeutics (CCCC) News

NASDAQ: CCCCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.48+0.04 (+1.64%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CCCC news summary

We found 5 recent headlines mentioning C4 Therapeutics (CCCC): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, CCCC is up 1.64% at $2.48. The most recent story, "C4 Therapeutics Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Nov 5, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest C4 Therapeutics headlines

Compare CCCC